suberosanone: from marine gorgonian Subergorgia suberosa; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 10353423 |
| CHEMBL ID | 513220 |
| CHEBI ID | 195999 |
| MeSH ID | M0501770 |
| Synonym |
|---|
| suberosanone |
| CHEMBL513220 |
| CHEBI:195999 |
| (1s,2r,5s,6s,9s)-2,9,11,11-tetramethyltricyclo[4.3.2.01,5]undecan-3-one |
| Class | Description |
|---|---|
| diterpenoid | Any terpenoid derived from a diterpene. The term includes compounds in which the C20 skeleton of the parent diterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups). |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID378279 | Cytotoxicity against mouse P388 cells by MTT method | 2000 | Journal of natural products, Dec, Volume: 63, Issue:12 | New cytotoxic sesquiterpenes from the gorgonian Isis hippuris. |
| AID378280 | Cytotoxicity against human A549 cells by MTT method | 2000 | Journal of natural products, Dec, Volume: 63, Issue:12 | New cytotoxic sesquiterpenes from the gorgonian Isis hippuris. |
| AID378281 | Cytotoxicity against human HT29 cells by MTT method | 2000 | Journal of natural products, Dec, Volume: 63, Issue:12 | New cytotoxic sesquiterpenes from the gorgonian Isis hippuris. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.07) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||